Shelly Gunn

Dr. Shelly Gunn M.D., Ph.D. serves as the Chief Medical Officer of ResearchDx and is the Medical Director for PacificDx Clinical Laboratory, a subsidiary of ResearchDx, since November 2015. With extensive expertise in molecular pathology, Dr. Gunn has held several leadership roles, including Chief Medical Officer at Molecular Health and Medical Director positions at Oncopath Laboratory, Ascend Genomics, LLC, and CombiMatrix Corporation. Dr. Gunn earned an MD and PhD in Clinical Pathology from UT Health San Antonio.